Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence

BACKGROUND: There is no randomized clinical trials with recurrence of atherosclerotic cardiovascular disease (ASCVD) as a major outcome with rosuvastatin. In order to analyze potential differences in the clinical response to atorvastatin and rosuvastatin in secondary ASCVD prevention, we have analyz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lipids Health Dis
Main Authors: Perez-Calahorra, Sofía, Laclaustra, Martin, Marco-Benedi, Victoria, Pinto, Xavier, Sanchez-Hernandez, Rosa M., Plana, Núria, Ortega, Emilio, Fuentes, Francisco, Civeira, Fernando
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905000/
https://ncbi.nlm.nih.gov/pubmed/31829197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-019-1153-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados